Procept BioRobotics Corp’s filing revealed that its Officer SHAM SHIBLAQ acquired Company’s shares for reported $1.28 million on Jun 06 ’25. In the deal valued at $64.13 per share,20,000 shares were bought.
Then, Shiblaq Hisham sold 20,000 shares, generating $1,282,637 in total proceeds. Upon selling the shares at $64.13, the EVP, Chief Comm. Officer now owns 63,133 shares.
Before that, Desai Antal Rohit sold 25,000 shares. Procept BioRobotics Corp shares valued at $1,619,830 were divested by the Director at a price of $64.79 per share. As a result of the transaction, Desai Antal Rohit now holds 89,363 shares, worth roughly $5.7 million.
Morgan Stanley initiated its Procept BioRobotics Corp [PRCT] rating to an Overweight in a research note published on December 02, 2024; the price target was $105. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid November with a ‘”a Hold”‘ rating. Piper Sandler began covering PRCT with “an Overweight” recommendation on August 11, 2023. William Blair started covering the stock on May 31, 2023. It rated PRCT as “an Outperform”.
Price Performance Review of PRCT
On Friday, Procept BioRobotics Corp [NASDAQ:PRCT] saw its stock jump 1.42% to $63.75. Over the last five days, the stock has gained 6.28%. Procept BioRobotics Corp shares have fallen nearly -20.83% since the year began. Nevertheless, the stocks have fallen -6.72% over the past one year.
Levels Of Support And Resistance For PRCT Stock
The most recent change occurred on October 31, 2022 when BTIG Research began covering the stock and recommended ‘”a Neutral”‘ rating .
